Skip to main content
Erschienen in: BMC Ophthalmology 1/2013

Open Access 01.12.2013 | Research article

Survey of policy for MRSA screening in English cataract surgical units and changes to practice after updated National guidelines

verfasst von: Lavnish Joshi, Stephanie K West, Luke Herbert

Erschienen in: BMC Ophthalmology | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

National guidelines on MRSA (methicillin-resistant Staphylococcus aureus) screening policy in England have changed on a number of occasions, but there is limited data on its influence at a local level. The aim of this study was to determine if changes in National policy influenced preoperative screening of cataract patients for MRSA.

Methods

A structured telephone survey was conducted on all 133 ophthalmology units in England in 2004 and again in 2007 for the initial responders, after a change in national policy.

Results

A total of 74 units (56%) responded in 2004 and 71 units (96% of initial respondents) in 2007. In 2004, 57% of units screened for MRSA. They screened groups at high risk of carriage, including patients with previous MRSA (93%) and patients from Nursing homes (21%). Swab sites included the nose (100%), eyes (31%) and perineum (62%). In 2007, there was no significant change in the number of units that screened for MRSA (57% vs 66%; p = 0.118; McNemar test). However, more units screened for MRSA in patients from nursing/residential homes (21% vs 51%; p = 0.004, McNemar test), and in patients who had recent admission to hospital (12% vs 36%; p = 0.003). In the second survey, 3 units (6%) now screened patients who were close relatives of MRSA carriers.

Conclusion

This survey has highlighted inconsistences in MRSA screening practice of day-case cataract surgery patients across England after 2 major national policy changes. A change in DoH policy only led to more units screening patients for MRSA from high risk groups.
Literatur
1.
Zurück zum Zitat Plowman R, Graves N, Griffin MA, Roberts JA, Swan AV, Cookson B, Taylor L: The rate and cost of hospital-acquired infections occurring in patients admitted to selected specialties of a district general hospital in England and the national burden imposed. J Hosp Infect. 2001, 47 (3): 198-209. 10.1053/jhin.2000.0881.CrossRefPubMed Plowman R, Graves N, Griffin MA, Roberts JA, Swan AV, Cookson B, Taylor L: The rate and cost of hospital-acquired infections occurring in patients admitted to selected specialties of a district general hospital in England and the national burden imposed. J Hosp Infect. 2001, 47 (3): 198-209. 10.1053/jhin.2000.0881.CrossRefPubMed
2.
Zurück zum Zitat Washer P, Joffe H: The “hospital superbug”: social representations of MRSA. Soc Sci Med. 2006, 63 (8): 2141-2152. 10.1016/j.socscimed.2006.05.018.CrossRefPubMed Washer P, Joffe H: The “hospital superbug”: social representations of MRSA. Soc Sci Med. 2006, 63 (8): 2141-2152. 10.1016/j.socscimed.2006.05.018.CrossRefPubMed
3.
Zurück zum Zitat Ayliffe PGAJ, Buckles MA, Casewell MW, Cookson BD, Cox RA, Duckworth GJ, French GL, Griffiths-Jones MA, Heathcock R, Humphreys H, et al: Revised guidelines for the control of methicillin-resistant Staphylococcus aureus infection in hospitals: report of a combined working party of the British Society for Antimicrobial Chemotherapy, the Hospital Infection Society and the Infection Control Nurses Association. J Hosp Infect. 1998, 39 (4): 253-290. 10.1016/S0195-6701(98)90293-6.CrossRef Ayliffe PGAJ, Buckles MA, Casewell MW, Cookson BD, Cox RA, Duckworth GJ, French GL, Griffiths-Jones MA, Heathcock R, Humphreys H, et al: Revised guidelines for the control of methicillin-resistant Staphylococcus aureus infection in hospitals: report of a combined working party of the British Society for Antimicrobial Chemotherapy, the Hospital Infection Society and the Infection Control Nurses Association. J Hosp Infect. 1998, 39 (4): 253-290. 10.1016/S0195-6701(98)90293-6.CrossRef
4.
Zurück zum Zitat Coia JE, Duckworth GJ, Edwards DI, Farrington M, Fry C, Humphreys H, Mallaghan C, Tucker DR: Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. J Hosp Infect. 2006, 63 (S1): S1-S44.CrossRefPubMed Coia JE, Duckworth GJ, Edwards DI, Farrington M, Fry C, Humphreys H, Mallaghan C, Tucker DR: Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. J Hosp Infect. 2006, 63 (S1): S1-S44.CrossRefPubMed
5.
Zurück zum Zitat Department of Health: Screening for meticillin-resistant Staphylococcus aureus (MRSA) colonization – A Strategy for NHS trusts: Summary of best practice. 2006, England: Department of Health Department of Health: Screening for meticillin-resistant Staphylococcus aureus (MRSA) colonization – A Strategy for NHS trusts: Summary of best practice. 2006, England: Department of Health
6.
Zurück zum Zitat Royal College of Ophthalmologists: The Directory of Training Posts 2003–4. 2003, London: Hawker Publications Royal College of Ophthalmologists: The Directory of Training Posts 2003–4. 2003, London: Hawker Publications
7.
Zurück zum Zitat Rathod D, Luqmani N, Webber SK, Hosein IK: Survey of meticillin-resistant Staphylococcus aureus policies in UK eye departments. J Hosp Infect. 2009, 72 (4): 314-318. 10.1016/j.jhin.2009.04.015.CrossRefPubMed Rathod D, Luqmani N, Webber SK, Hosein IK: Survey of meticillin-resistant Staphylococcus aureus policies in UK eye departments. J Hosp Infect. 2009, 72 (4): 314-318. 10.1016/j.jhin.2009.04.015.CrossRefPubMed
8.
Zurück zum Zitat Deramo VA, Lai JC, Winokur J, Luchs J, Udell IJ: Visual Outcome and Bacterial Sensitivity After Methicillin-Resistant Staphylococcus aureus-Associated Acute Endophthalmitis. Am J Ophthalmol. 2008, 145 (3): 413-417. 10.1016/j.ajo.2007.10.020.CrossRefPubMed Deramo VA, Lai JC, Winokur J, Luchs J, Udell IJ: Visual Outcome and Bacterial Sensitivity After Methicillin-Resistant Staphylococcus aureus-Associated Acute Endophthalmitis. Am J Ophthalmol. 2008, 145 (3): 413-417. 10.1016/j.ajo.2007.10.020.CrossRefPubMed
9.
Zurück zum Zitat Major JC, Engelbert M, Flynn HW, Miller D, Smiddy WE, Davis JL: Staphylococcus aureus endophthalmitis: antibiotic susceptibilities, methicillin resistance, and clinical outcomes. Am J Ophthalmol. 2010, 149 (2): 278-283. 10.1016/j.ajo.2009.08.023.CrossRefPubMed Major JC, Engelbert M, Flynn HW, Miller D, Smiddy WE, Davis JL: Staphylococcus aureus endophthalmitis: antibiotic susceptibilities, methicillin resistance, and clinical outcomes. Am J Ophthalmol. 2010, 149 (2): 278-283. 10.1016/j.ajo.2009.08.023.CrossRefPubMed
10.
Zurück zum Zitat Han DP, Wisniewski SR, Wilson LA, Barza M, Vine AK, Doft BH, Kelsey SF: Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study. Am J Ophthalmol. 1996, 122 (1): 1-17.CrossRefPubMed Han DP, Wisniewski SR, Wilson LA, Barza M, Vine AK, Doft BH, Kelsey SF: Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study. Am J Ophthalmol. 1996, 122 (1): 1-17.CrossRefPubMed
11.
Zurück zum Zitat Fukuda M, Ohashi H, Matsumoto C, Mishima S, Shimomura Y: Methicillin-resistant Staphylococcus aureus and methicillin-resistant coagulase-negative Staphylococcus ocular surface infection efficacy of chloramphenicol eye drops. Cornea. 2002, 21 (7): S86-S89.CrossRefPubMed Fukuda M, Ohashi H, Matsumoto C, Mishima S, Shimomura Y: Methicillin-resistant Staphylococcus aureus and methicillin-resistant coagulase-negative Staphylococcus ocular surface infection efficacy of chloramphenicol eye drops. Cornea. 2002, 21 (7): S86-S89.CrossRefPubMed
12.
Zurück zum Zitat Reimer K, Wichelhaus TA, Schafer V, Rudolph P, Kramer A, Wutzler P, Ganzer D, Fleischer W: Antimicrobial effectiveness of povidone-iodine and consequences for new application areas. Dermatology. 2002, 204 (S1): 114-120.CrossRefPubMed Reimer K, Wichelhaus TA, Schafer V, Rudolph P, Kramer A, Wutzler P, Ganzer D, Fleischer W: Antimicrobial effectiveness of povidone-iodine and consequences for new application areas. Dermatology. 2002, 204 (S1): 114-120.CrossRefPubMed
13.
Zurück zum Zitat Rutar T, Chambers HF, Crawford JB, Perdreau-Remington F, Zwick OM, Karr M, Diehn JJ, Cockerham KP: Ophthalmic manifestations of infections caused by the USA300 clone of community-associated methicillin-resistant Staphylococcus aureus. Ophthalmology. 2006, 113 (8): 1455-1462. 10.1016/j.ophtha.2006.03.031.CrossRefPubMed Rutar T, Chambers HF, Crawford JB, Perdreau-Remington F, Zwick OM, Karr M, Diehn JJ, Cockerham KP: Ophthalmic manifestations of infections caused by the USA300 clone of community-associated methicillin-resistant Staphylococcus aureus. Ophthalmology. 2006, 113 (8): 1455-1462. 10.1016/j.ophtha.2006.03.031.CrossRefPubMed
14.
Zurück zum Zitat Vandenesch F, Naimi T, Enright MC, Lina G, Nimmo GR, Heffernan H, Liassine N, Bes M, Greenland T, Reverdy ME, et al: Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis. 2003, 9 (8): 978-984. 10.3201/eid0908.030089.CrossRefPubMedPubMedCentral Vandenesch F, Naimi T, Enright MC, Lina G, Nimmo GR, Heffernan H, Liassine N, Bes M, Greenland T, Reverdy ME, et al: Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis. 2003, 9 (8): 978-984. 10.3201/eid0908.030089.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Sax H, Harbarth S, Gavazzi G, Henry N, Schrenzel J, Rohner P, Michel JP, Pittet D: Prevalence and prediction of previously unknown MRSA carriage on admission to a geriatric hospital. Age Ageing. 2005, 34 (5): 456-462. 10.1093/ageing/afi135.CrossRefPubMed Sax H, Harbarth S, Gavazzi G, Henry N, Schrenzel J, Rohner P, Michel JP, Pittet D: Prevalence and prediction of previously unknown MRSA carriage on admission to a geriatric hospital. Age Ageing. 2005, 34 (5): 456-462. 10.1093/ageing/afi135.CrossRefPubMed
16.
Zurück zum Zitat Eveillard M, Charru P, Rufat P, Hippeaux MC, Lancien E, Benselama F, Branger C: Methicillin-resistant Staphylococcus aureus carriage in a long-term care facility: hypothesis about selection and transmission. Age Ageing. 2008, 37 (3): 294-299. 10.1093/ageing/afn021.CrossRefPubMed Eveillard M, Charru P, Rufat P, Hippeaux MC, Lancien E, Benselama F, Branger C: Methicillin-resistant Staphylococcus aureus carriage in a long-term care facility: hypothesis about selection and transmission. Age Ageing. 2008, 37 (3): 294-299. 10.1093/ageing/afn021.CrossRefPubMed
17.
Zurück zum Zitat Scriven JM, Silva P, Swann RA, Thompson MM, Naylor AR, Bell PRF, London NJM: The Acquisition of Methicillin-resistant Staphylococcus aureus (MRSA) in Vascular Patients. Eur J Vasc Endovasc Surg. 2003, 25 (2): 147-151. 10.1053/ejvs.2002.1829.CrossRefPubMed Scriven JM, Silva P, Swann RA, Thompson MM, Naylor AR, Bell PRF, London NJM: The Acquisition of Methicillin-resistant Staphylococcus aureus (MRSA) in Vascular Patients. Eur J Vasc Endovasc Surg. 2003, 25 (2): 147-151. 10.1053/ejvs.2002.1829.CrossRefPubMed
18.
Zurück zum Zitat Miller MA, Dascal A, Portnoy J, Mendelson J: Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment. Infect Control Hosp Epidemiol. 1996, 17 (12): 811-813. 10.1086/647242.CrossRefPubMed Miller MA, Dascal A, Portnoy J, Mendelson J: Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment. Infect Control Hosp Epidemiol. 1996, 17 (12): 811-813. 10.1086/647242.CrossRefPubMed
19.
Zurück zum Zitat Simor AE, Loeb M, Committee CCG: The management of infection and colonization due to methicillin-resistant Staphylococcus aureus: a CIDS/CAMM position paper. Can J Infect Dis. 2004, 15 (1): 39-48.CrossRefPubMedPubMedCentral Simor AE, Loeb M, Committee CCG: The management of infection and colonization due to methicillin-resistant Staphylococcus aureus: a CIDS/CAMM position paper. Can J Infect Dis. 2004, 15 (1): 39-48.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Pittet D, Hugonnet S, Harbarth S, Mourouga P, Sauvan V, Touveneau S, Perneger TV: Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Lancet. 2000, 356 (9238): 1307-1312. 10.1016/S0140-6736(00)02814-2.CrossRefPubMed Pittet D, Hugonnet S, Harbarth S, Mourouga P, Sauvan V, Touveneau S, Perneger TV: Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Lancet. 2000, 356 (9238): 1307-1312. 10.1016/S0140-6736(00)02814-2.CrossRefPubMed
Metadaten
Titel
Survey of policy for MRSA screening in English cataract surgical units and changes to practice after updated National guidelines
verfasst von
Lavnish Joshi
Stephanie K West
Luke Herbert
Publikationsdatum
01.12.2013
Verlag
BioMed Central
Erschienen in
BMC Ophthalmology / Ausgabe 1/2013
Elektronische ISSN: 1471-2415
DOI
https://doi.org/10.1186/1471-2415-13-80

Weitere Artikel der Ausgabe 1/2013

BMC Ophthalmology 1/2013 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Die überschießende Wundheilung in der filtrierenden Glaukomchirurgie ist ein zentraler Faktor für ein operatives Versagen. Nach der Einführung der Trabekulektomie in den 1960er-Jahren wurden viele Faktoren erkannt, die mit einer vermehrten …

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.